Lärkberget AB (publ) (STO:COMBI)

Market Cap	44.95M
Revenue (ttm)	2.00M
Net Income (ttm)	-44.88M
Shares Out	19.80M
EPS (ttm)	-2.27
PE Ratio	n/a
Forward PE	n/a
Dividend	0.20 (8.58%)
Ex-Dividend Date	Jun 13, 2025

Volume	8,157
Average Volume	60,602
Open	2.490
Previous Close	2.470
Day's Range	2.470 - 2.490
52-Week Range	1.270 - 3.060
Beta	1.22
RSI	48.98
Earnings Date	Aug 22, 2025

About Lärkberget AB

CombiGene AB (publ) operates as an investment company. It is involved in Direct investments in low-risk instruments; Financial investments; Direct investments in unlisted profitable companies; and Reverse acquisition platform. The company was formerly known as CombiGene AB (publ) and changed its name to Lärkberget AB (publ) in June 2025. Lärkberget AB (publ) was incorporated in 1990 and is based in Östermalm, Sweden.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1990
• Employees: 9
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: COMBI

Financial Performance

In 2024, Lärkberget AB's revenue was 2.00 million, a decrease of -71.47% compared to the previous year's 7.01 million. Losses were -44.88 million, 25.8% more than in 2023.